All News
Great results presented at #EULAR24 by Greg Dresler on CD19/BCMA CAR T-cell therapy. 18 additional SLE patients with great response. @LUPUSDK @LupusEurope https://t.co/2C64ECzq83
Anne Troldborg TroldborgAnne ( View Tweet)
Another excellent oral presentation from UPMC myositis center by Shiri Keret at #EULAR2024. She showed that many myositis patient may have normal CK despite muscle weakness. However, CK is associated with outcomes over time even in patients with normal or near normal CK,… https://t.co/nAoUo8fcXh https://t.co/J8iZG4eESP
Links:
Rohit Aggarwal docrota ( View Tweet)
✅ Updated pipeline of phase 2 & 3 trials in #Lupus ⬇️ #EULAR2024
Please let me know if something is missing or incorrect 👍 https://t.co/ruuKYmAvYj
Laurent ARNAUD Lupusreference ( View Tweet)
John H Stone’s #IgG4RD lessons:
1-It is a variable-vessel vasculitis
2-more common/severe in males (2:1)
3-Has no diagnostic histopathology
4-IgG4 does not cause IgG4RD
5-Serum igg4 is a good biomarker
6-Rising IgG4 shouldn’t be ignored
#EULAR2024 https://t.co/7p6pBqI4ue
Vasco C Romao romaovc ( View Tweet)
#EULAR2024 the benefit of in person conference. Meeting colleagues IRL @KDAO2011 @RADoctor https://t.co/g0JH5s0mcD
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
RA specific bone signatures (markers) detected by machine learning. Abst#0125
Dkk1 increased in erosive RA #EULAR2024 @RheumNow https://t.co/0A5C9LCzle
Bella Mehta bella_mehta ( View Tweet)
Fibroblasts activated -> secrete chemokines which lead to granzyme K production inturn leading to damage to mitochondria - release of mitochondrial DNA and production of interferon type 1 which ultimately lead to infiltrates (which contribute to the worsening saliva production) https://t.co/jZkU3SBhwc
Links:
Bella Mehta bella_mehta ( View Tweet)
Single cell analysis with 12 groups
Those patient without lymphocytic infiltrates were different!
Mitochondria were the differentiator in these patients.
Fibroblasts and CD8+ T cells are the most actively communicating cells. - Chemokines and ECM https://t.co/Pe0WSoYdXT
Links:
Bella Mehta bella_mehta ( View Tweet)
Tenosynovitis, bone marrow lesions and synovitis quantification in #RA #MRI
Labelled data and training sets are the key!
#EULAR2024 @rheumnow abst#0190 https://t.co/irDaFrxBH5
Links:
Bella Mehta bella_mehta ( View Tweet)
Deep learning software to evaluate CTD-ILD abst#0167
Lots of computer vision/ imaging performance studies at #EULAR2024
Using segmentation to evaluate lung abnormalities @rheumnow https://t.co/9aXIymAM6X
Links:
Bella Mehta bella_mehta ( View Tweet)
🗣️Lowering glucocorticoids dose remains a key goal in #lupus management
Prof @EricFMorand at #EULAR2024
#letpushbelow5 mg of prednisone in #SLE https://t.co/IeiLh2zVrT
Matteo Piga RMD_clinic ( View Tweet)
End stage Knee Oa predictive tool 2 to 5 years now available online.
using MOST and OAI open access data #EULAR2024 abst#0203
@RheumNow
Can help in more efficient Knee OA clinical trials. https://t.co/AhhoczsuHU
Links:
Bella Mehta bella_mehta ( View Tweet)
#EULAR2024
Reminder …
🔺Anti-drug antibodies cause significant variability in Therapeutic drug levels
🔺10% have undetectable drug level after 3 months of Rx
🔺is therapeutic drug monitoring is beneficial? 🤔 https://t.co/ChgMnKPyFb
Dr Gurdeep S Dulay gurdeep_dulay ( View Tweet)
Cardiovascular risk prediction in #RA using #AI chest xray imaging improves accuracy abst#0146 @RheumNow #EULAR2024 https://t.co/wtF5Sel8Tx
Links:
Bella Mehta bella_mehta ( View Tweet)
RISK OF NON-MELANOMA SKIN CANCER WITH TNFi AND OTHER bDMARDs IN PATIENTS WITH PSORIATIC ARTHRITIS: A SWEDISH AND DANISH COHORT STUDY- despite having minimal sun 25% increase NMSC TNFis vs other bDMARDs - skin checks !@rheumnow #EULAR2024
Peter Nash drpnash ( View Tweet)
steroid dose 120 mg , repeated if not in remission 12 wks on background MTX - no difference between groups @rheumnow #EULAR2024 https://t.co/gkqmElfOCp
Peter Nash drpnash ( View Tweet)
Deep learning to predict if an #RA patient will benefit from treatment using MRIs abst#0182
Models are still not good for mainstream practice- but will be in the future!
Lots of fine tuning required #EULAR2024 #EULARBest @rheumnow https://t.co/9yVN6CHLCv
Links:
Bella Mehta bella_mehta ( View Tweet)
dual IL 17 A & F nanobody typical response at 12 wks not significantly better - how many IL17 inhibs do we need? @RheumNow #EULAR2024 https://t.co/50dIKyO0e4
Peter Nash drpnash ( View Tweet)
Was a full room #EULAR2024 for the SELECT-GCA presentation (upadacitinib in GCA positive study). Palpable excitement through the audience here in Vienna
@RheumNow https://t.co/bFL6mqqFAa
David Liew drdavidliew ( View Tweet)